This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Redding, S. W. Articles by Rinaldi, M. G. Search for Related Content PubMed PubMed Citation Articles by Redding, S. W. Articles by Rinaldi, M. G.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, 07 1997, 1761-1765, Vol 35, No. 7
Copyright © 1997 by the American Society for Microbiology. All rights reserved.

Variations in fluconazole susceptibility and DNA subtyping of multiple Candida albicans colonies from patients with AIDS and oral candidiasis suffering one or more episodes of infection

SW Redding, MA Pfaller, SA Messer, JA Smith, J Prows, LL Bradley, AW Fothergill and MG Rinaldi
Department of General Dentistry, University of Texas Health Science Center, San Antonio 78284, USA.

Five Candida albicans colonies from each infection in AIDS patients receiving fluconazole therapy for oropharyngeal candidiasis over a 2- year period were evaluated by antifungal susceptibility testing and DNA subtyping, and the results were correlated with clinical response to determine the occurrence of clinically significant selection of more- resistant C. albicans over multiple infections. A total of 534 C. albicans isolates were obtained from 38 patients who exhibited 84 episodes of infection. Antifungal susceptibility testing revealed that the MICs for 93% of the isolates were < or = 8.0 microg/ml and the MICs for 7% of the isolates were > or = 64 microg/ml. DNA subtyping revealed 70 different subtypes, with 78% of patients with one infection exhibiting one DNA subtype and 80% of patients with more than one infection exhibiting multiple DNA subtypes. Also, patients who had multiple infections had lower CD4 counts than those with single infections. Differences between the single-infection group and the multiple-infection group regarding the number of DNA subtypes and CD4 counts were both statistically significant. Of the 74 evaluable infections all were successfully treated with regular-dose (100-mg/day) fluconazole, except for three patients who ultimately responded to higher-dose fluconazole. Only one patient may have shown clinically significant selection of a more-resistant C. albicans strain over multiple courses of treatment. Interestingly, MICs reached only 8.0 microg/ml, even though doses of 400 mg of fluconazole were necessary for clinical cure.

This article has been cited by other articles:

• de Repentigny, L., Lewandowski, D., Jolicoeur, P. (2004). Immunopathogenesis of Oropharyngeal Candidiasis in Human Immunodeficiency Virus Infection. Clin. Microbiol. Rev. 17: 729-759 [Abstract] [Full Text]  
• Samaranayake, Y.H., Samaranayake, L.P., Dassanayake, R.S., Yau, J.Y. Y., Tsang, W.K., Cheung, B.P. K., Yeung, K.W. S. (2003). `Genotypic shuffling' of sequential clones of Candida albicans in HIV-infected individuals with and without symptomatic oral candidiasis. J Med Microbiol 52: 349-359 [Abstract] [Full Text]  
• Vargas, K. G., Joly, S. (2002). Carriage Frequency, Intensity of Carriage, and Strains of Oral Yeast Species Vary in the Progression to Oral Candidiasis in Human Immunodeficiency Virus-Positive Individuals. J. Clin. Microbiol. 40: 341-350 [Abstract] [Full Text]  
• Samaranayake, Y. H., Samaranayake, L. P., Pow, E. H. N., Beena, V. T., Yeung, K. W. S. (2001). Antifungal Effects of Lysozyme and Lactoferrin against Genetically Similar, Sequential Candida albicans Isolates from a Human Immunodeficiency Virus-Infected Southern Chinese Cohort. J. Clin. Microbiol. 39: 3296-3302 [Abstract] [Full Text]  
• Xu, J., Ramos, A. R., Vilgalys, R., Mitchell, T. G. (2000). Clonal and Spontaneous Origins of Fluconazole Resistance in Candida albicans. J. Clin. Microbiol. 38: 1214-1220 [Abstract] [Full Text]  
• Martin, M. V. (1999). The use of fluconazole and itraconazole in the treatment of Candida albicans infections: a review. J Antimicrob Chemother 44: 429-437 [Abstract] [Full Text]